Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment

IMPORTANCE: The prevalence of persistent diabetic macular edema (DME) after months of anti–vascular endothelial growth factor therapy and its effect on visual acuity are unknown. OBJECTIVE: To assess subsequent outcomes of eyes with DME persisting for 24 weeks after initiating treatment with 0.5 mg...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Ophthalmol
Autores principales: Bressler, Susan B., Ayala, Allison R., Bressler, Neil M., Melia, Michele, Qin, Haijing, Ferris, Frederick L., Flaxel, Christina J., Friedman, Scott M., Glassman, Adam R., Jampol, Lee M., Rauser, Michael E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4786449/
https://ncbi.nlm.nih.gov/pubmed/26746868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2015.5346
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares